Learning Zone
Chronic Spontaneous Urticaria
Are you up to date with the latest strategies in managing chronic spontaneous urticaria (CSU)? Gain clinical insights into the emerging therapies shaping the future of CSU treatment, plus updates on diagnosis and personalized care.
- Catch up with the latest guideline-recommended and in-development CSU treatments, and review personalized care strategies
- Recap key concepts on CSU burden, pathophysiology, and presentation
- Hear expert perspectives to help you optimize outcomes for your patients
- Stay informed on the evolving CSU treatment landscape by exploring highlights from EAACI 2025, and identify ongoing gaps in patient care
- Watch our interview with Gülseren Tuncay, MD (Ankara, Türkiye), for insights from EAACI 2025 and future directions in CSU management
This content has been developed independently by Medthority who previously received educational funding from Novartis in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.